Quest Diagnostics Incorporated
DGX · NYSE
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $9,872,000 | $9,252,000 | $9,883,000 | $10,788,000 |
| % Growth | 6.7% | -6.4% | -8.4% | – |
| Cost of Goods Sold | $6,628,000 | $6,199,000 | $6,450,000 | $6,579,000 |
| Gross Profit | $3,244,000 | $3,069,000 | $3,433,000 | $4,209,000 |
| % Margin | 32.9% | 33.2% | 34.7% | 39% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $1,770,000 | $1,615,000 | $1,874,000 | $1,727,000 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $128,000 | $192,000 | $131,000 | $101,000 |
| Operating Expenses | $1,898,000 | $1,807,000 | $2,005,000 | $1,828,000 |
| Operating Income | $1,346,000 | $1,262,000 | $1,428,000 | $2,381,000 |
| % Margin | 13.6% | 13.6% | 14.4% | 22.1% |
| Other Income/Exp. Net | -$152,000 | -$106,000 | -$149,000 | $296,000 |
| Pre-Tax Income | $1,194,000 | $1,156,000 | $1,279,000 | $2,677,000 |
| Tax Expense | $273,000 | $248,000 | $264,000 | $597,000 |
| Net Income | $871,000 | $854,000 | $946,000 | $1,995,000 |
| % Margin | 8.8% | 9.2% | 9.6% | 18.5% |
| EPS | 7.8 | 7.59 | 8.12 | 15.9 |
| % Growth | 2.8% | -6.5% | -48.9% | – |
| EPS Diluted | 7.69 | 7.52 | 7.98 | 15.53 |
| Weighted Avg Shares Out | 111,000 | 112,000 | 116,000 | 125,000 |
| Weighted Avg Shares Out Dil | 113,000 | 113,000 | 118,000 | 128,000 |
| Supplemental Information | – | – | – | – |
| Interest Income | $25,000 | $11,000 | $10,000 | $1,000 |
| Interest Expense | $226,000 | $163,000 | $148,000 | $152,000 |
| Depreciation & Amortization | $493,000 | $439,000 | $437,000 | $408,000 |
| EBITDA | $1,894,000 | $1,732,000 | $1,820,000 | $3,159,000 |
| % Margin | 19.2% | 18.7% | 18.4% | 29.3% |